ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,437, issued on Jan. 13, was assigned to SYNTHORX INC. (Morristown, N.J.).
"IL-2 conjugates and methods of use thereof" was invented by Jerod Ptacin (San Diego), Carolina E. Caffaro (San Diego) and Marcos Milla (Carlsbad, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions, kits, and methods comprising interleukin (IL) conjugates (e.g., IL-2 conjugates) useful for the treatment of one or more indications. Also described herein are pharmaceutical compositions and kits comprising one or more of the interleukin conjugates (e.g., IL-2 conjugates)."
The patent was filed on June 17, 2021, under Application No. 17/350,67...